Core Viewpoint - The recent sale of shares by James Poppens, Vice President of Interface (NASDAQ:TILE), raises questions about insider trading dynamics, particularly in the context of the company's recent performance and market conditions [6][7]. Group 1: Insider Trading Activity - Poppens sold 25,650 shares over four consecutive trading days, generating approximately $736,000 in total proceeds, indicating a significant reduction in his ownership position [6][4]. - His direct ownership decreased by roughly 19.7%, from 129,496 to 103,846 shares during this selling period [4]. - This sale represents the most concentrated selling activity in Poppens's recent history, exceeding the recent per-trade median of 14,350 shares [5]. Group 2: Market Context and Company Performance - The timing of the sale coincided with a decline in TILE's stock price, which fell from $29.42 on March 3 to $28.05 on March 6, suggesting Poppens sold into a weakening price environment [3]. - Despite the insider selling, Interface reported record results for 2025, with Q4 earnings per share of $0.49, surpassing the analyst consensus of $0.40, and raised its dividend by 50% [7]. - The commercial flooring sector, particularly in office, healthcare, and education, remains resilient, indicating that the company's fundamentals are strong despite the insider selling [8].

Company Overview - Interface Inc. is a global supplier of modular flooring solutions, including carpet tiles, resilient flooring, rubber flooring, and luxury vinyl tile, along with installation systems and antimicrobial compounds [8][9] - The company generates revenue through direct sales to end-users, independent distributors, and online channels, complemented by project management and maintenance services [8] - Interface serves various commercial sectors, including offices, healthcare, education, hospitality, and retail, with a presence in North America, Europe, and Asia-Pacific [9] Financial Metrics - The company's market capitalization is $1.49 billion [5] - Revenue for the trailing twelve months (TTM) is reported at $1.39 billion [5] - Net income for the TTM stands at $116.10 million [5] Recent Transaction - On March 6, 2026, Vice President James Poppens sold 8,000 shares of common stock at an average price of $28.05 per share, totaling approximately $224,400 [1][2] - Post-transaction, Poppens holds 103,846 shares directly, valued at approximately $2.9 million based on the market close on the same day [2] - The sale represents 7.15% of Poppens's pre-transaction holdings of 111,846 shares [7] Market Performance - The stock was up around 38% year over year on the day of the sale, having peaked at an intraday high of $35.11 on February 9, 2026 [10] - Following the sale, the stock has cooled to a 26% gain [10] - The transaction size is smaller compared to Poppens's recent median sell size of 14,350 shares per trade, indicating a reduced share base due to prior sales [4][7]

Core Insights - Tabor Asset Management increased its stake in Mohawk Industries by purchasing 85,224 shares, bringing its total holdings to 154,292 shares, with an estimated transaction value of $9.79 million [2][6] Company Overview - Mohawk Industries reported a trailing twelve months (TTM) revenue of $10.79 billion and a net income of $369.90 million [4] - The current share price of Mohawk Industries is $103.44, reflecting a 9% decline over the past year, underperforming the S&P 500's approximate 18% gain during the same period [6] Business Model and Market Position - Mohawk Industries is a global leader in flooring solutions, offering a diverse product portfolio that includes ceramic and porcelain tile, natural stone, carpet, hardwood, laminate, and vinyl [7] - The company operates a vertically integrated business model, which encompasses design, manufacturing, sourcing, distribution, and marketing, generating revenue from both residential remodeling and new construction as well as commercial projects [7][8] - Mohawk serves a global customer base, targeting homeowners, builders, contractors, and commercial clients across various international markets [7] Financial Performance and Cash Flow - Despite challenges in the housing market, Mohawk generated approximately $10.8 billion in revenue and around $370 million in net earnings in 2025 [9] - The company produced about $621 million in free cash flow last year, allowing management to repurchase 1.3 million shares and invest in productivity improvements [10] Investment Context - The decision by Tabor Asset Management to invest in Mohawk Industries during a tough housing market indicates a strategic move, as the company operates across various flooring products and markets [9] - The position in Mohawk fits within a broader portfolio of consumer and discretionary names, suggesting potential benefits when consumer spending and housing activity rebound [11]

Company Overview - Mohawk Industries, Inc. offers a wide range of flooring products for both residential and commercial markets globally, distributing to customers in the United States, Europe, Russia, and other international markets [6][9] - The company operates a vertically integrated business model, generating revenue through product sales to residential and commercial construction, remodeling, and renovation markets worldwide [9] Financial Performance - For the trailing twelve months (TTM), Mohawk Industries reported revenue of $10.8 billion and a net income of $369.9 million [4] - As of February 13, 2026, the company's market capitalization was $8.2 billion, with shares priced at $132.60, reflecting a 9.6% increase over the last year, although it lagged the S&P 500 by 2.2 percentage points [4][8] Recent Developments - Union Square Park Capital Management, LLC sold its entire 40,000-share position in Mohawk Industries during the fourth quarter, which was valued at $5.1 million, representing 1.8% of the fund's reported assets [2][10] - The liquidation of the stake follows a period where Mohawk shares have struggled to find growth in a weak housing market, with the stock currently 62% off its previous peak [10] - Mohawk's adjusted revenue was down 3% year over year in the last quarter, and management indicated that market conditions in the first quarter are expected to be similar to those in the fourth quarter, although they anticipate improvements in the economies of most markets where they operate [11]

Group 1: Fund Performance - Ariel Fund delivered a +3.22% return in Q4 2025, in line with Russell 2500 Value Index (+3.15%) and Russell 2000 Value Index (+3.26%) [1] - For the trailing one-year period, the Fund advanced 14.15%, outperforming Russell 2500 Value Index (+12.73%) and Russell 2000 Value Index (+12.59%) [1] - The Fund's 5- and 10-year average annual returns were +9.36% and +9.51%, respectively [1] Group 2: Market Conditions and Outlook - Performance attributed to resilient corporate earnings, easing inflation, and rising expectations for accommodative monetary policy [1] - Continued enthusiasm around artificial intelligence and cloud infrastructure supported markets, although gains were concentrated in large-cap stocks [1] - The firm maintains a cautious outlook for 2026, citing geopolitical risks, fiscal constraints, labor market dynamics, and elevated market concentration as potential volatility sources [1] Group 3: Mohawk Industries, Inc. Overview - Mohawk Industries, Inc. is a global flooring manufacturer producing various products for residential and commercial markets [2] - The one-month return for Mohawk Industries was -6.57%, with shares trading between $96.24 and $143.13 over the last 52 weeks [2] - As of March 5, 2026, Mohawk Industries stock closed at approximately $108.70 per share, with a market capitalization of about $6.57 billion [2] Group 4: Mohawk Industries, Inc. Performance Insights - Mohawk Industries faced headwinds from the housing market, impacting consumer demand, pricing, and input costs [3] - Management provided lower near-term guidance compared to Street expectations amid macro uncertainty, despite earnings results being relatively in-line [3] - The company is better positioned than peers due to domestically sourced products and ongoing cost restructuring, with new product momentum driving market share gains in North America [3]

Performance Overview - River Oaks Capital's performance since inception shows a return of 73.7% compared to benchmarks like Russell 2000 TR at 61.2% and S&P 500 TR at 132.2% [2] Investment Philosophy - The investment strategy focuses on identifying small, underfollowed public companies that are undervalued and have strong management teams [7][10] - The approach emphasizes rigorous due diligence and active engagement with management to enhance shareholder value [11][12] Company Strategies - **Ascent Industries (ACNT)**: A specialty chemical manufacturer with a market cap of $150 million, focusing on transforming into a 'Chemicals-as-a-Service' model to serve small to mid-size customers [60][88] - **BuildDirect (BILD.V)**: A flooring company with a market cap of $90 million, pursuing a strategy to consolidate the professional flooring industry through acquisitions, aiming for 75+ centers [89][92] - **Truxton Trust (TRUX)**: A financial institution maintaining low operational costs while generating consistent free cash flow, operating efficiently like a private company [40][42] Recent Developments - Ascent Industries has improved gross margins from 5% to ~30% by adjusting pricing and focusing on higher-margin product sales [74][86] - BuildDirect's recent acquisition of Greyn Custom Wood is expected to generate significant incremental revenue and cost savings, enhancing its market position [92][94] Capital Allocation - Ascent Industries plans to utilize its $60 million cash balance for growth investments, share buybacks, and disciplined acquisitions [83][88] - BuildDirect is positioned to grow revenue significantly through strategic acquisitions and operational improvements, targeting a revenue of ~$165 million in the next 2-3 years [110] Market Conditions - The flooring industry is currently experiencing a downturn, leading to lower acquisition prices for professional centers, which presents a favorable environment for strategic acquisitions [102][103]

Core Insights - Interface reported a record year in 2025 with all-time highs in net sales, adjusted operating income, and adjusted EBITDA, driven by broad-based regional and segment growth, price and volume gains across all product categories, and operational improvements [4][7] Financial Performance - For the full year 2025, Interface achieved net sales of $1.39 billion, a 5.4% increase year-over-year, with adjusted EBITDA of $217.9 million and adjusted EPS of $1.94, reflecting a 33% increase [7][17] - Fourth-quarter net sales were $349.4 million, up 4.3% as reported and 1.6% on a currency-neutral basis, with adjusted gross margin at 38.6%, up 169 basis points [13][14] Growth Drivers - Global healthcare billings increased by 21% year-over-year in 2025, while education billings rose by 8%, attributed to expanded offerings at more approachable price points [1] - The combined U.S. selling team model across carpet tile, LVT, and nora Rubber has enhanced cross-selling effectiveness, contributing to a 17% increase in global rubber billings [2] Strategic Initiatives - The "One Interface" strategy focuses on strengthening global functions to support local selling teams, improving commercial productivity, and expanding margins through global supply chain management [3] - Interface launched "noravant," a PVC-free rubber sheet platform, expected to contribute $5–10 million in 2026 and potentially $50–100 million over five years [6][9] Capital Allocation and Outlook - For 2026, Interface projects net sales of $1.42–$1.46 billion and capital expenditures of about $55 million, while also extending its debt and increasing the quarterly dividend to $0.03 per share [5][19] - The company entered 2026 with solid orders and a healthy backlog, up 7% year-to-date, despite macroeconomic uncertainties [19] Sustainability Efforts - Sustainability remains a central theme, with Interface offering low-carbon products and incorporating captured carbon in manufacturing processes, recognized in various sustainability rankings [12]

Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, Adjusted Operating Income, and Adjusted EBITDA, with currency-neutral net sales increasing by 4% year-over-year [4][14] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales in the Americas increasing by 5.5% and in EAAA by 2.4% [21][22] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and nora Rubber) experienced growth in both price and volume [5] - Global rubber billings increased by 17% in 2025 compared to the prior year [6] - Healthcare billings were up 21% year-over-year, while education billings increased by 8% [14][15] Market Data and Key Metrics Changes - In the Americas, currency-neutral net sales increased by 5% year-over-year, particularly strong in healthcare and education segments [14] - EAAA region saw a 2% increase in currency-neutral net sales, reflecting improving trends despite a challenging macro environment [14] - Corporate office billings were slightly up, with a focus on Class A spaces [15] Company Strategy and Development Direction - The company is committed to the "One Interface" strategy, focusing on global functions to support local selling teams and enhancing commercial productivity [4] - Continued investments in automation and robotics are expected to drive productivity gains and margin expansion [7][8] - The launch of Noravant, a new rubber flooring innovation, aims to expand the addressable market in the resilient category [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth driven by strong demand in healthcare and education, supported by macro tailwinds [15][16] - For 2026, the company expects net sales of $1.42 billion to $1.46 billion, with an adjusted gross profit margin of approximately 38.5%-39% [28][29] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [24] - Capital expenditures for 2025 were $46.2 million, with an expected increase to $55 million in 2026 to support automation initiatives [25] - The board approved an increase in the quarterly dividend from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams in the U.S., with healthcare billings up 21% and nora business up 17% [34] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [36][38] Question: How is the corporate market performing compared to healthcare and education? - Management indicated that the corporate business was flat, with retail business being soft, but healthcare and education showed strong growth [46][47] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across initiatives, providing confidence entering 2026 [50][51] Question: How is SG&A being managed while pursuing growth? - Management emphasized disciplined spending and variable compensation tied to revenue, ensuring efficient use of resources [54][55] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs diluted gross profit percentage by around 20 basis points in 2025, with an anticipated 50 basis points impact in 2026 [91] Question: Can you provide global billings by category for Q4? - Management reported that corporate was flat, education was up 11.6%, and healthcare was up 11.7% [105]

Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, adjusted operating income, and adjusted EBITDA, marking the highest levels in its history [4] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales increasing 4.3% [21] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and rubber) grew in both price and volume [5] - Global healthcare billings were up 21% year-over-year, with double-digit gains in the Americas and EAAA [14] - Education billings increased 8% for the full year, reflecting the success of expanded collection offerings [15] - Corporate office billings were up slightly for the year, with a focus on gaining share in Class A spaces [15] Market Data and Key Metrics Changes - Currency-neutral net sales in the Americas increased 5.5%, while EAAA saw a 2.4% increase [21] - The company reported a 2% increase in consolidated currency-neutral orders year-over-year [20] - The healthcare and education sectors are experiencing increased investment, driven by aging populations and modernization efforts [15] Company Strategy and Development Direction - The "One Interface" strategy focuses on building strong global functions to support local selling teams and enhancing commercial productivity [4] - The company is committed to sustainability, with initiatives including the launch of a cradle-to-gate carbon negative rubber prototype [12] - The introduction of the noravant product line is expected to open new design possibilities and expand the addressable market [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth in 2026, with a focus on expanding its addressable market through innovative products and pricing strategies [16] - Management acknowledged ongoing macro uncertainties but highlighted a solid order backlog and healthy growth expectations [27] Other Important Information - The company plans to increase capital expenditures to $55 million in 2026 to support automation and productivity initiatives [25] - A quarterly dividend increase from $0.02 to $0.03 per share was approved, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams, with healthcare billings up 21% and expectations for continued growth through the launch of noravant [35][36] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [38][39] Question: What is the outlook for the corporate market? - Management indicated that the corporate market remains competitive, with growth expectations aligned with strong demand in Class A spaces [48] Question: Can you elaborate on the backlog increase? - Management described the backlog as solid and well-distributed across various initiatives, providing confidence for entering 2026 [51][53] Question: How is the company managing SG&A expenses? - Management emphasized a disciplined approach to SG&A, focusing on investments that drive growth while maintaining efficiency [56][57] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs had a dilutive impact on gross profit percentage, with expectations for modest inflation in raw materials [95][96]

Financial Data and Key Metrics Changes - 2025 was a record year for the company, with net sales, Adjusted Operating Income, and Adjusted EBITDA reaching their highest levels in history, driven by the One Interface strategy [4] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales increasing 4.3% [18] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [19] - Adjusted EPS was $1.94, a 33% increase compared to $1.46 [20] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and rubber) grew in both price and volume, with global rubber billings up 17% in 2025 [5][12] - Healthcare billings were up 21% year-over-year, while education billings increased 8% [12][13] - Corporate office billings were up slightly, reflecting a competitive market environment [14] Market Data and Key Metrics Changes - Currency-neutral net sales in the Americas increased 5.5%, while EAAA saw a 2.4% increase, indicating improving trends in international markets [18] - The healthcare sector is experiencing increased investment due to aging populations and a focus on preventative care, benefiting the company [13] - The corporate market remains competitive, with Class A spaces in demand, particularly in major cities like New York and San Francisco [44][64] Company Strategy and Development Direction - The One Interface strategy focuses on building strong global functions to support local selling teams, enhancing commercial productivity, and expanding margins through supply chain management [4] - The company is committed to sustainability, with a focus on low-carbon products and innovative solutions like the new Noravant rubber flooring [11][9] - Future growth will be driven by expanding addressable markets through innovative product offerings and maintaining a disciplined approach to SG&A expenses [15][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education markets [6] - The company anticipates continued growth in 2026, with a focus on leveraging successful strategies and expanding product offerings [14][24] - Management acknowledged ongoing macro uncertainties but remains optimistic about solid orders and a healthy backlog entering 2026 [24] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [21] - Capital expenditures were $46.2 million in 2025, with expectations to increase to $55 million in 2026 to support automation and productivity initiatives [22] - The quarterly dividend was increased from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [23] Q&A Session Summary Question: Can you elaborate on the One Interface selling strategy? - Management highlighted the success of the combined selling teams and the potential for further expansion in healthcare and education markets [29][30] Question: What are the expectations for gross margins in 2026? - Management indicated that gross margins are expected to continue improving, driven by automation and efficiency initiatives [33][34] Question: How is the corporate market performing compared to healthcare and education? - Management noted that while corporate business was flat, healthcare and education saw significant growth, with ongoing demand in Class A spaces [42][44] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across various initiatives, providing confidence for 2026 [47][49] Question: How is SG&A being managed while pursuing growth opportunities? - Management emphasized disciplined spending and a focus on variable compensation tied to revenue, ensuring efficiency [52][56] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs had a dilutive impact on gross profit percentage, with expectations for continued monitoring and adjustments [93][94]